Based on these results, the authors proposed that increasing CBP expression in adult brains might be a valid therapeutic approach that may not be limited to AD but may also be effective in other brain disorders in which CREB-dependent gene expression is impaired. This evidence concerns the gene CREBBP and Alzheimer disease.